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infection in porcine alveolar macrophages (PAMs). We identified a cell surface protein, 48 integrin β3 (ITGB3), as an interacting protein with receptor of activated protein C kinase 1 49 (RACK1) from Marc-145 cells. ITGB3 interacts with RACK1 and facilitates PRRSV 50 Porcine reproductive and respiratory syndrome (PRRS) is characterized by respiratory 61 disorders in piglets and reproductive failure in sows (1). The contributing pathogen, porcine 62 reproductive and respiratory syndrome virus (PRRSV), is a swine-specific enveloped single-63 stranded positive-sense RNA virus that belongs to the family Arteriviridae, genus Arterivirus 64
(2). Since the first PRRS outbreak in the united states in 1987, PRRSV infections is nowadays 65 detectable in almost all swine-producing countries, causing one of the highest economic 66 impacts in modern pig production worldwide (3). Several cell surface receptors that are 67 involved in PRRSV infection in porcine alveolar macrophages (PAMs) has been identified, 68
including heparan sulphate (HS) (4), sialoadhesin (Sn) (5) and CD163 (6, 7) . 69
Integrins are a family of heterodimer transmembrane receptors consisting of eighteen α-70 subunits and eight β-subunits that play pivotal roles in the binding of cells to extracellular 71 matrix (ECM) (8, 9) , transmembrane signal transduction (10, 11) and immune responses (12) . 72
Cellular integrins are common receptors exploited by diverse viral pathogens for cell entry 73 and infection (13) , such as Epstein-Barr virus (EBV)(14), human immunodeficiency virus 1 74 (HIV-1) (15, 16) and Simian virus 40 (17) . The signalling functions of integrins are conducted 75 through the formation of signalling complexes at the cytoplasmic face of the plasma 76 membrane with its cofactors, for example focal adhesion kinase (FAK) (18) and receptor of 77 activated protein C kinase 1 (RACK1) (19, 20) . 78 RACK1 , a 36-kDa protein comprising of seven WD-40 repeats, is well known as a 79 scaffolder protein (21) and plays its unique functions in various cancers (22) (23) (24) and 80 infections (24-28). RACK1 serves as an adaptor molecule for the binding of key signaling 81 molecules (19, (22) (23) (24) (29) (30) (31) ,with elaborate involvement in the regulation of multiple signal 82 pathways (24, 30, 32) . RACK1 is reported to interact with β integrins to stabilize the focal 83 adhesion through cell-ECM interaction with the entanglement of integrin-induced FAK 84 autophosphoryation (19, 31, 33) . 85
Nuclear factor kappa beta (NF-κB), whose activation by a variety of signals regulates the 86 expression of many target genes, is a key regulator of cellular events. NF-κB signaling 87 pathway modulates a broad range of biological processes including immune response, 88 inflammation, cell proliferation, tumorigenesis and apoptosis. Binding of the viral particle to 89 its receptors and the accumulation of viral products, including dsRNA and viral proteins, 90 activate NF-κB signaling cascades through various processes. Multiple viruses, including HIV 91 (34, 35) , herpesviruses (36), and hepatitis C virus (HCV) (37), have in turn evolved 92 sophisticated strategies to alert NF-κB signaling. 93
Our previous studies (26, 28) showed that RACK1 is indispensable for PRRSV 94 replication and NF-κB activation in Marc-145 cells. As a build-up of that concept, the current 95 study identified integrin β3 (ITGB3) as a interacting factor of RACK1 during the PRRSV 96 infection in Marc-145 cells. Our data indicate that PRRSV infection upregulates the 97 expression of RACK1 interacting ITGB3, which participates in the activation of the NF-κB 98 signaling pathway, which in turn promotes PRRSV infection, presumably through regulation 99 of RACK1 and ITGB3. The findings can advance our elaborated understanding of the 100 molecular host-pathogen interaction mechanisms of PRRSV and suggest ITGB3 and NF-κB 101 signaling pathway as potential therapeutic targets for PRRS control. 102
103

RESULTS
104
ITGB3 was identified as a RACK1 interacting protein. Venny diagram analysis 105
(https://bioinfogp.cnb.csic.es/tools/venny/) of the four datasets from the pulldown-MS assay 106
( Supplementary Table 1 ) revealed that there were 179 RACK1-interacting proteins shared 107 within all the four infection time points (Fig. 1A ). Further gene ontology 108 (http://amigo.geneontology.org/amigo/landing) pathway analysis ( Fig. 1B) of the 179 109 overlapping proteins showed that integrin signaling pathway (including ITGB3 and its related 110 factors such as ILK, ACTN1, PIK3C2A, MAPK3 and FYN) is one of the most enriched 111 pathways. As strong evidence has demonstrated that RACK1 could interact with a number of 112 integrins during various physiological processes and pathogenesis (19, 24, 31, 38) , ITGB3 113 was therefore chosen for the following studies. The mRNA and amino acids sequences of 114 ITGB3 from eighteen species were downloaded for phylogenetic analysis using online tool 115
Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/ ) with the default parameters 116 ( Supplementary Fig. 1A and 1B ). The ITGB3 amino acid sequence is highly conserved 117 between human, monkey and pig ( Supplementary Fig. 2) . 118 Moreover, antibody blocking showed more pronounced inhibitory effects on PRRSV 131 replication and NF-κB induction. 132
Abrogation of ITGB3 inhibited PRRSV replication and NF-κB activation in Marc-
Overexpression of ITGB3 enhanced PRRSV replication and NF-κB activation in 133
Marc-145 cells. Transfection of ITGB3 expression vector increased the ITGB3 level, while 134 combination with PRRSV further elevated the ITGB3 expression ( Fig. 3A ). Overexpression 135 of ITGB3 also induced the phosphorylation of IκBα ( Fig. 3B ) and expression of RACK1 ( Fig upregulation, which is confirmed by the immunoflueorescence data ( Fig. 4) . 142
Loss-of-function of ITGB3 protected Marc-145 cells from cytopathic effects and 143
reduced the viral titer. Change of cytopathic effects (CPE) and viral titer are among the 144 most direct and undoubted parameters in virus research. We found that compared with the 145 controls (non-treatment, siCtrl and Isotype antibody) where severe CPEs were manifested till 146 dilution of 10 -5 , loss-of-function of ITGB3 by siITGB3 or antibody blocking could 147 significantly protect Marc-145 cells from CPE at the viral dilution between 10 -3 and 10 -4 ( Fig.  148 5). The TCID 50 titer of PRRSV was reduced by 40-72 times when ITGB3 was knocked-down 149 or by approximate 300 times when blocked with ITGB3 specific antibody ( Fig. 5) . 150 RACK1 and ITGB3 are NF-κB target genes. The mouse RACK1 gene was reported to 151 be regulated by NF-κB (39), however, there is no evidence to show whether the RACK1 and 152 ITGB3 from monkey kidney Marc-145 cell line are target genes of NF-κB. As expected, 153 besides the phosphorylation of IκBα and p65 ( Fig. 6E and 6G ), which confirmed our previous 154 findings (26, 28), PRRSV infection enhanced the expression of ITGB3 and RACK1 ( Fig. 6A RACK1 is well known to interact with the membrane proximal region of the cytoplasmic 176 tail of integrins β1 (20, 24), β2 (40), β3 (38) and β5 (31). The first identification of integrin β3 177 (ITGB3) as a RACK1-interacting protein by pulldown and mass spectrometry in cell in this study is consistent with previous discoveries in other species. Besides, some other 179 RACK1 interacting and ITGB3 related proteins (e.g., ILK, ACTN1, PIK3C2A, FYN and 180 ERK1) are enriched in the integrin signaling pathway and worth further investigation. 181
The primary target cells of PRRSV infection in vivo are PAMs. However, due to lack of 182 stable and immortal PAM cell lines, Marc-145 cells are extensively used for PRRSV basic 183 research as it is highly permissive for PRRSV infection. In this study, PRRSV infection in 184
Marc-145 cells led to the upregulation of the ITGB3 expression. Overexpression of ITGB3 in 185 turn elevated PRRSV replication and strengthened the NF-κB activation. Abolishment of 186 ITGB3 repressed PRRSV replication and inhibited the NF-κB activation. Furthermore, 187 downregulation of ITGB3 protected the Marc-145 cells from the cytopathic effects and 188 abridged the viral titer. All these results indicated the pivotal role of ITGB3 in PRRSV 189 infection, with the underlying mechanisms for further investigations. 190
Vimentin was identified as an important part of the PRRSV receptor complex in . It has been reported that the vimentin head domain bound to the ITGB3 cytoplasmic 192 tail (42). As a cell surface protein, ITGB3 is known to be involved in the cell entry of West 193
Nile Virus (43), Herpes Simplex Virus (44), Japanese Encephalitis Virus (45) and Mouth Disease Virus (46). It is logical to hypothesize that ITGB3 is also a part of the PRRSV 195 receptor complex and play its roles in the attachment and entry of PRRSV. More interestingly, 196 the infection of PRRSV displayed positive feedback effect on the expression of ITGB3, as 197 observed also in Swine Fever Virus (47, 48) and Dengue Virus (49). 198
Activation of NF-κB is a hallmark of most viral infections and the viral pathogens in 199 many cases hijack NF-κB pathway to their own advantages (50). Suppression of NF-κB and 200 the subsequent delay of detectable viral mRNA and N protein after ITGB3 knockdown 201 implied that the NF-κB activation after PRRSV is beneficial for its infection/replication. 202
Previous study showed that the mouse RACK1 gene was regulated by NF-κB activated by 203 nerve growth factor (NGF) in PC-12 cells (39). In line with that, we showed that monkey 204 RACK1 was a NF-κB target gene during PRRSV infection in Marc-145 cells. Moreover, our 205 data for the first time indicated that ITGB3 was a novel NF-κB target gene. Presumably, 206
PRRSV infection in Marc-145 cells activated NF-κB signal pathway to transcribe its target 207 genes, including RACK1 and ITGB3, which in turn facilitated the PRRSV 208 infection/replication. 209
As a NF-κB inhibitor, BAY 11-7082 has been widely used to investigate the effects of 210 NF-κB inhibition on diverse physiological and pathogenic processes (51), as well as in 211 PRRSV infection (52). However, inhibition of NF-κB signal pathway alone by BAY 11-7082 212 could not completely nullify the PRRSV replication in Marc-145 cells (Fig. 6H ). This 213 suggests that the parameters for NF-κB inhibition (concentration and time) were not optimal 214 or/and that NF-κB activation might only partially contributes to PRRSV infection. We 215 speculate that some other signal pathways may be involved in and indispensable for PRRSV 216 infection. Indeed, there have been a number of studies illustrating the relationship between 217 PRRSV infection and mTOR signaling pathway (53) To further complicate the situations, there can be some other regulatory molecules mediating 226 RACK1 and ITGB3. As a receptor for activated protein kinase C, RACK1 was shown to form 227 a phorbol 12-myristate 13-acetate (PMA)-induced complex between PKCε and integrin β1 or 228 β5 in human glioma cells (38). Human articular chondrocytes express PKCα, γ, δ, ι and λ, and 229 upon stimulation chondrocytes show a rapid, integrin β1 dependent, translocation of PKCα to 230 the cell membrane and increased association of RACK1 with PKCα and β1 integrin (57). We 231 therefore contemplate one or more PKC members may play some certain roles together with 232 RACK1 and ITGB3 during the NF-κB pathway induced by PRRSV infection. 233
In conclusion, ITGB3 plays an imperative role during PRRSV infection and NF-κB 234 activation in Marc-145 cells, presumably as a co-receptor for example with vimentin or 235 CD163; PRRSV infection activates a positive feedback loop involving the activation of NF-236 κB and upregulation of ITGB3 and RACK1 in Marc-145 cells (Fig. 8) . However, the 237 mechanistic linkage among PRRSV infection, the expression and interaction between RACK1 238 and ITGB3, and the NF-κB signaling pathway desires further investigations. Our data would 239
shed new light on the underlying mechanisms of PRRSV infection in swine and suggested 240 RACK1-ITGB3-NF-κB signaling axis as a promising potential therapeutic target for PRRS 241 control. 242
243
MATERIAL AND METHODS 244
Most of the materials and methods used in this study were described with details in our 245 previous studies (26, 28, 58, 59) . 246
Virus and cells. The highly pathogenic PRRSV strain YN-1, which belongs to the 247 PRRSV genotype 2 (the North American genotype), was isolated by our lab (TCID 50 = 10 -5.5 , 248
GenBank accession number KJ747052). The highly PRRSV permissive grivet monkey kidney 249 derived Marc-145 cells were used as cell model in this study. 250
Pulldown and mass spectrometry analyses of RACK1 binding partners. Briefly, full 251 length RACK1 cDNA was cloned from Marc-145 cell with the primer pair RACK1-F and 252 Table 1 ). After sequencing confirmation, the cDNA was subcloned into a 253 prokaryotic expression vector (pET32a, EMD Biosciences) with a 6xHis tag. Recombinant 254
RACK1-R (listed in
His-RACK1 bait protein was expressed in E.coli BL21 (DE3) cells and incubated with Ni-255 NTA resin. Meanwhile, Marc-145 cells were infected with 100 TCID 50 for 2 hr, 24 hr and 48 256 hr, respectively, with non-infected cells (0 hr) as control. Sufficient amount of total protein 257 (100 µg/ml) from each group was extracted and loaded to the affinity column containing His-258 RACK1 which were bound to Ni-NTA for affinity Pulldown of target proteins. After washing, 259 the isolated proteins were eluted and identified by mass spectrometry. More detailed protocol 260 is included in the Supplementary Material and Methods. 261 siRNA transfection. Transfections were performed in 6-well plates with 3×10 5 cells 262 seeded into 2 ml complete medium forty-eight hours before infection with YN-1 strain. Forty 263 nM siRNAs against ITGB3 or RACK1 or non-targeting siRNA (sequences listed in Table 1 , 264 purchased from Sangon, Shanghai, China) were premixed with 6 µl Lipofectamine 3000 in 265
OptiMEM and added to each well. siRACK1-pool is the mixture of the two siRNAs with 266 equal concentration against RACK1 used in our previous study (26) . Transfection with non-267 targeting siRNA (siCtrl) was used as neutral control for normalization or comparison with the 268 specific knockdowns. 269
Treatment with ITGB3 antibody and NF-κB inhibitor BAY 11-7082. Briefly, 3×10 5 270
Marc-145 cells in 2 ml cell culture medium were seeded into 6-well plate and cultured 271 overnight. Then the cells were incubated with either an antibody specifically binding to 272 ITGβ3 or a Mouse mAb IgG2b Isotype control (listed in Table 2 ) at 25 μg/ml (45) for 2 h at 273 37 °C, followed by medium change and PRRSV infection. For NF-κB inhibition, Marc-145 274 cells were pre-treated with 10 μM BAY 11-7082 (#B5556-10MG, Sigma-Aldrich) for 2 hours, 275 followed by medium change and PRRSV infection. DMSO at 10 μM was applied as negative 276
control. 277
Virus infection. Forty-right hours post transfection with siRNA or overexpression 278 plasmids, or two hours post antibody blocking or NF-κB inhibition, the Marc-145 cells were 279 inoculated with 100 TCID 50 PRRSV YN-1 strain per well for 2 hrs. Then the virus was 280 withdrawn by medium change and the cells were kept in culture till further analysis. 281
Total RNA isolation and RT-qPCR analysis. Total RNA was isolated using RNAiso 282
Plus RNA isolation kit ( #9108/9109, Takara, Dalian, China) from Marc-145 cells at different 283 time points (1, 2, 4, 12, 24, 36, 48 and 60 hpi) according to the manufacturer's instructions. 284
RT-qPCR was performed to determine the relative expression level of viral ORF7 gene for 285
quantification with cellular GAPDH served as an internal control (primer sequences are listed 286
in Table 1) . 287
Overexpression of ITGB3 in Marc-145 cells. Briefly, ITGB3 cRNA was reverse transcribed 288 and amplified from Marc-145 total RNA with three pairs of primers (listed in Supplementary  289 Materials and Methods) designed according to its sequence (GenBank seq. No. 290 XM_005584610.2) and resulted in three fragmented sequences with restrict enzyme adapter at 291 each end. After sequencing confirmation, the ITGB3 fragments were enzymatically digested, 292 purified and ligated to pcDNA™3.1/Hygro(+) mammalian expression vector (#V87520, 293
Thermofisher Scientific, MA, USA). More detailed protocol is included in the Supplementary 294
Materials and Methods. 295
Marc-145 cells (3×10 5 ) were cultured in 2 ml medium in 6-well plates until 70-80% 296 confluence, followed by transfection with 3 μg expression plasmid (pcDNA3.1-ITGB3) or 297 empty vector (pcDNA3.1) and 3.75 µl Lipofectamine 3000. Twenty-four hours post 298 transfection, the cells were inoculated with PRRSV YN-1 strain (2000 TCID 50 /well, 299 equivalent to an approximate MOI of 5) till further analysis. Transfection with empty vector 300 and cells without infection were used as controls for normalization or comparison with the 301 specific overexpression of ITGB3. 302
Western blot analysis. Total viral and cellular proteins were extracted with RIPA buffer 303 at the indicated time points and denatured immediately by boiling in SDS-PAGE loading 304 buffer. After separated by electroporation and transferred to nitrocellulose membrane, the 305 proteins of interest were detected with antibodies as listed in Table 2 at indicated dilutions. 306
The blots were developed with chemiluminescent ECL Plus substrate and visualized using 307 chemiluminescent film. 308 Indirect immunofluorescence staining. Twenty-four hours post transfection of ITGB3 309 overexpression plasmid, the cells were inoculated with PRRSV YN-1 strain (2000 310 TCID 50 /well). Transfection with empty vector and cells without infection were used for 311 comparison. Forty-eight hours post PRRSV infection, the Marc-145 cells were washed with 312 PBS (0.05 M, pH7.4) and fixed with 4% paraformaldehyde (PFA) at room temperature for 313 10-15 minutes. Then the cells were washed with PBS for three times, permeabilizated with 314 PBS containing 0.3% Triton X-100 for 15 minutes and blocked with PBS containing 1% BSA 315 for 2 hours at 4 °C. The nuclei staining with 5 μg/ml of Hoechst 33342 (Sigma-Aldrich, Cat. 316 #B2261) was carried out for 20 minutes at room temperature to visualize the nuclei. The cells 317
were subsequently co-incubated with PRRSV antibody against N protein and anti-ITGB3 318 antibody at 4 °C overnight, washed three times with PBS and then co-incubated with 319 corresponding secondary antibody for 1 h at 37 °C (all antibody information is listed in Table  320 2). After three times PBS wash, the cells were subjected to image analysis by fluorescence 321 microscopy (Olympus). 322 TCID 50 measurement after ITGB3 siRNA transfection and antibody blocking. Marc-323 145 cells were seeded into 96-well plates with10000 cells per well. Forty-eight hours post 324 siRNA knockdown or 2 hours post antibody blocking, a 10× serial dilution of PRRSV YN-1 325 strain was prepared and added into the cells with hexatruple replicates in each concentration. 326
Cytopathological effects (CPE) were monitored using the inverted microscope over 3 days 327 post infection. Well number was counted and the 50% tissue culture infected does (TCID 50 ) 328 was determined by Reed-Muench method. Non-treated cells, cells transfected with non-329 targeting siRNA or blocked with unspecific IgG antibody were used as control. BAY 11-7082 alleviates PRRSV replication in Marc-145 cells through TRAF2 and its 579 phosphorylation. Marc-145 cells were infected with PRRSV YN-1 strain two hours after or 580 without pre-treatment with BAY 11-7082. The cells at different time points (2, 12, 24, 36, 48 581 and 60 hpi) were collected for western blot against RACK1 (A), ITGB3 (B), TRAF2 (C), 582 phosphor-TRAF2 (D), phosphorylated-IκBα (E), p65 (F), phosphorylated-p65 (G), viral N 583 protein (H) and GAPDH (I). Non-infected cells were applied as control. (non-targeting control, siITGB3 and siRACK1), Marc-145 cells were infected with PRRSV 587 YN-1 strain (100 TCID 50 ) or without infection. Total protein was collected at the indicated 588 infection time points (1, 2, 4, 12, 24, 36, 48 and 60 hpi) Non-treatment
